Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-03-02 @ 6:03 PM
Study NCT ID:
NCT01743859
Status:
COMPLETED
Last Update Posted:
2019-10-08
First Post:
2012-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
Sponsor:
University of Colorado, Denver
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
12-1283.cc
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |